Tasmania
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nelson, Mark
NCT04707625: Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Terminated
4
17
US
Aflibercept Ophthalmic, Eylea
Wake Forest University Health Sciences
Retinal Vein Occlusion
12/23
12/23
NCT04075136: Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Withdrawn
4
150
US
Ranibizumab, Lucentis, Photodynamic laser treatment (PDT), Triamcinolone Acetonide, Triesence, verteporfin, Visudyne
Wake Forest University Health Sciences, Modulight
Exudative Age Related Macular Degeneration
11/24
12/24
STAREE, NCT02099123: A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly

Active, not recruiting
4
9971
RoW
Atorvastatin, Lipitor, , , Cadivast, Caduet, Lorstat, Torvastat, Trovas, Atorachol, Cadatin, Placebo (for Atorvastatin), no other names
Monash University, National Health and Medical Research Council, Australia, National Heart Foundation, Australia
Independent Living, Disability Free Survival, Elderly, Healthy
12/25
12/25

Download Options